-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
MoonLake Immunotherapeutics quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2022 to Q1 2025.
- MoonLake Immunotherapeutics Depreciation, Depletion and Amortization for the quarter ending March 31, 2025 was $378K, a 15.2% increase year-over-year.
- MoonLake Immunotherapeutics annual Depreciation, Depletion and Amortization for 2024 was $1.38M, a 274% increase from 2023.
- MoonLake Immunotherapeutics annual Depreciation, Depletion and Amortization for 2023 was $370K, a 125% increase from 2022.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)